Litcius/Paper detail

Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study

Marie-Charlotte Trojani, D. Gensburger, F. Bagouet, Bernard Cortet, G. Couture, Christian Marcelli, N. Mehsen Cetre, Véronique Breuil, Roland Chapurlat

2023Bone26 citationsDOIOpen Access PDF

Topics & Concepts

DenosumabMedicineBisphosphonateFibrous dysplasiaRefractory (planetary science)Bone Density Conservation AgentsOncologyInternal medicineSurgeryOsteoporosisBone densityPhysicsAstrobiologyBone Tumor Diagnosis and TreatmentsDermatological and Skeletal DisordersBone health and treatments
Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study | Litcius